|
| Exchange Disseminated Time 20/05/2017 14:31:29 | Gufic Biosciences Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 29, 2017, inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2017 and recommend dividend on Equity shares for the financial year 2016-17, if any.
Further, pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and as per the terms of "Code of Conduct for Insider Trading" adopted by the Company, the trading window shall be closed from May 20, 2017 and re-open on June 01, 2017. The communication has been circulated to all Directors, Officers and Designated Employees of the Company. |
|
|